Subject: EASL supports liver cancer awareness month
From: EASL Office <[email-masked]>
To: [email-masked]
Date: Wed, 14 Oct 2020 06:28:42 +0000

Browse open-access educational resources on liver cancer

October 2020

Read online

Liver cancer is the fourth leading cause of cancer-related deaths worldwide, being the second and sixth most common cause of cancer death in men and women, respectively. In patients with cirrhosis, it represents the primary cause of death. Most liver cancers are hepatocellular carcinomas (HCCs), however some patients develop intrahepatic cholangiocarcinomas (ICCs) or rare tumours in non-cirrhotic livers.

Chronic liver diseases, alcohol consumption, obesity and diabetes, non-alcoholic fatty liver disease (NAFLD), aflatoxins exposure as well as chronic infection with hepatitis B (HBV) or C (HCV), are considered risk factors. Just this month, the 2020 Nobel Prize awarded three scientists for their discovery of HCV, which leads to cirrhosis and liver cancer, and for their valuable contribution to its elimination.

The burden of adult liver cancers and HCC is still increasing and various public health strategies have been developed to prevent and control this trend, which is likely to remain a major global health problem in the decades ahead. [1],[2]

EASL is offering the liver community a collection of open-access educational resources on liver cancer, developed with worldwide experts in the field. Please find them below.

Digital ILC 2020 open-access Takeaways - Liver tumours

In this open-access EASL Takeaway, Prof. Maria Reig, Prof. Markus Peck, and Prof. Helen Reeves review the latest advances in cancer therapy, diagnostics, and prognostics presented at Digital ILC 2020.

Watch the debate

HCC management online course

Take the online course and assess your knowledge on the management of immune checkpoint inhibitors’ side effects in the treatment of HCC.

Take the course now

Digital ILC 2020

Liver tumours was one of the key topics at Digital ILC 2020. Experts and delegates from around the world discussed the latest research, novel treatments, and working together on improving patients’ lives.

All content is available exclusively to registered delegates. Browse through the resources, including Best of Digital Liver Tumours Slide Decks,  abstract & interactive sessions, ePosters, and more.

Access the resources or register

At Digital ILC 2020, nurses and AHPs held dedicated sessions on Liver Tumours, highlighting their engagement and the importance of their role in improving patients’ lives.

Access the resources or register

Revisit the open-access resources from our past events

Liver Cancer Summit 2020

Learn from the latest science on liver cancer, presented at the most important European summit on this topic.

See the resources

HCC Summit 2019

Discover 150+ open-access materials (including presentations, posters, etc.) from the HCC Summit 2019.

See the resources

ILC 2019

Explore 26 webcasts, 149 ePosters, and a synthesis in a downloadable Best of ILC 2019 Slide Deck.

See the resources

EASL Clinical Practice Guidelines

These CPGs give up-to-date advice on the clinical management of HCC patients and the management of  benign liver tumours. Each CPG comes with a downloadable Slide Deck.

Read & download them

Journal of Hepatology resources

Browse a collection of liver tumour related articles that have been published in the Journal of Hepatology, the best-ranked liver journal.

Read the articles

European Network for the Study of Cholangiocarcinoma (ENS-CCA)

The European Network for the Study of Cholangiocarcinoma (ENS-CCA) is an open, international network of scientists focused on the multidisciplinary study of CCA. This pan-European consortium was created in 2015 with the main aim of promoting collaborative research projects at the basic, translational and clinical levels.

The ENS-CCA is coordinating a European Registry of patients with CCA (competitively funded by EASL in 2016 and in 2019) with clinical, biochemical, histological information using the online platform REDCap. This registry is the basis of multiple ongoing collaborative projects, which include the use of biological samples of patients from participating institutions.

Save the date for the Digital Liver Cancer Summit 2021

[1] European Association for the Study of the Liver. Electronic address: [email-masked]; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5. Erratum in: J Hepatol. 2019 Apr;70(4):817. PMID: 29628281.

[2] Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014 Jun;60(6):1268-89. doi: 10.1016/j.jhep.2014.01.021. Epub 2014 Mar 27. PMID: 24681130.

Download the EASL app

Access event info, EASL Campus and stay informed with the latest messages and news.

For the latest news on hepatology and liver diseases, follow us on Twitter

@EASLnews and @EASLedu

Share with a friend or colleague

EASL’s mission is supported by an unrestricted education grant from Abbvie and Bristol-Myers Squibb.

EASL, The Home of Hepatology

7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60

www.easl.eu

[email-masked]

Update your preferences or unsubscribe